Transgene Biotek Limited., a active public limited company, was established on 01 March 1990 in Ida Bollaram, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: L85195TG1990PLC011065. Registered under ROC Roc Hyderabad. it is listed on BSE: 526139. It has an authorized capital of ₹76.00 Cr and a paid-up capital of ₹75.77 Cr.
It upholds a compliant status. Its leadership includes Kollipara Koteswara Rao (Managing Director), Swetha Marri (Director), Santhosh Kumar (Director). Past directors included Kollipara Koteswara Rao, Soma Sekhar Marthi, Puranik Sarang Subhash. It holds ₹18.53 Cr open charges and ₹3.92 Cr settled loans. Its latest AGM occurred on 05 December 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No:69 & 70, Ida Bollaram, Sangareddy District., Ida Bollaram, Telangana, 502325.
L85195TG1990PLC011065
011065
01 March 1990
₹76.00 Cr
₹75.77 Cr
Roc Hyderabad
Listed (BSE: 526139)
Active
Explore comprehensive insights into Transgene Biotek Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kollipara Koteswara Rao | Managing Director | 04 Mar 2020 | Current |
| Swetha Marri | Director | 03 Jun 2020 | Current |
| Santhosh Kumar | Director | 12 Nov 2019 | Current |
| Sujana Kadiam | Director | 17 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Mar 2020 | Past |
| Pramod Abcsdd | Director | 31 Dec 2014 | Past |
| Pramod Abcsdd | Director | 28 May 2018 | Past |
| Pramod Abcsdd | Director | 28 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 18 Feb 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Transgene Biotek Limited., for the financial year ended 2024, experienced significant growth in revenue, with a 81.19% increase. The company also saw a substantial improvement in profitability, with a 89.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Transgene Biotek had a promoter holding of 21.68% and a public holding of 78.32%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹185,298,247.00
₹39,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Apr 2025 | Others | ₹1.50 Cr | Open |
| 30 Jan 2025 | Others | ₹6.00 Cr | Open |
| 08 Apr 2010 | Department Of Biotechnology | ₹5.07 Cr | Open |
| 30 Jul 2008 | Ge Capital Services India | ₹0.86 M | Open |
| 30 May 2005 | The Karur Vysya Bank Ltd. | ₹5.94 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Transgene Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Transgene Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transgene Biotek's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101095247 was registered on 11 Apr 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 101044763 was registered on 30 Jan 2025. was recorded as a recent event.
The activity Transgene Biotek Limited. last Annual general meeting of members was held on 05 Dec 2024 as per latest MCA records. was completed.
The activity Transgene Biotek Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge registered on 23 May 2007 via Charge ID 10052981 with Union Bank Of India was fully satisfied on 25 May 2021. was recorded as a recent event.
Progress on Swetha Marri was appointed as a Director was appointed as a Director on 03 Jun 2020 & has been associated with this company since 5 years 7 months . was documented.
Besides, Transgene will continue the measures to recall the outstanding amount of USD 38.5 million and bring the money back into its bank account in India within a period of one year from the date... .
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies to transform the fight against solid tumors and infectious diseases, publishes its financial results for 2018 and provides an update on its clinical and preclinical portfolio, and its technology platforms..
The latest ruling comes after Securities and Exchange Board of India (Sebi) in November 2014, had ordered a detailed probe in this regard. .
The CIN of Transgene Biotek Limited. is L85195TG1990PLC011065.
Transgene Biotek Limited. is headquartered at Plot No:69 & 70, Ida Bollaram, Sangareddy District., Ida Bollaram, Telangana, 502325.
Transgene Biotek Limited. was incorporated on 01 March 1990.
The current directors of Transgene Biotek Limited. are
The primary industry of Transgene Biotek Limited. is Manufacturing.
Transgene Biotek Limited. is listed. It is listed on BSE: 526139.
The authorized capital of Transgene Biotek Limited. is ₹76.00 Cr, and the paid-up capital is ₹75.77 Cr.
The compliance status of Transgene Biotek Limited. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX